Action Point Financial Planning’s Ironwood Pharmaceuticals IRWD Stock Holding History

Action Point Financial Planning’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4K	Buy	+569	New	+$2.19K	﹤0.01%	2177

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Action Point Financial Planning's IRWD Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 569 shares worth $2.4K. The stake represents ﹤0.01% of the portfolio and ranks #2177 among its holdings.

211 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Action Point Financial Planning held 569 shares of Ironwood Pharmaceuticals worth $2.4K as of Q2 2026.
Ironwood Pharmaceuticals was a new Action Point Financial Planning position in Q2 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #2177 holding.
211 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.